A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT06031441 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06031441
Sponsor: Genentech, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Solid Tumors Recurrent Solid Tumors Metastatic Solid Tumors

Start date: 2023-11-27
Primary completion: 2027-03-03
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.